Cellectis (CLLS) Tops Q1 EPS by 7c

Cellectis (NASDAQ: CLLS) reported Q1 EPS of ($0.17), $0.07 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $12 million versus the consensus estimate of $11.96 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• Evercore ISI Double Upgrades Occidental Petroleum (OXY) to Outperform
• Kyung Hee University System Announces The Bulletin of the Atomic Scientists as the Recipient of the 2nd Miwon Peace Prize
• Goldman Sachs Upgrades Restoration Hardware (RH) to Neutral